/index.php?option=com_iwpfile&file=/dir_04/he2004_2837.pdf


/index.php?option=com_iwpfile&file=/dir_04/he2004_2836.pdf


NCI Scientists Create Model That Predicts Follicular Lymphoma Survival Scientists at the National Cancer Institute (NCI), part of the National Institutes of Health, have created a model that predicts the survival of follicular lymphoma patients based on the molecular characteristics of their tumors at diagnosis. The model is based on two sets of genes--called survival-associated signatures--whose activity was found to be associated with good or poor prognosis for patients with the cancer.



FDA Statement

FOR IMMEDIATE RELEASE

Statement

November 18, 2004

Media Inquiries: 301-827-6242

Consumer Inquiries: 888-INFO-FDA

Statement by Dr. Steven Galson, Acting Director, Center for Drug Evaluation and Research (CDER), Regarding November 18, 2004, Committee on Finance of the U.S. Senate Hearing on Drug Safety and the Worldwide Withdrawal by Merck & Co., Inc., of Vioxx











/index.php?option=com_iwpfile&file=/dir_04/he2004_2829.pdf


/index.php?option=com_iwpfile&file=/dir_04/he2004_2828.pdf


Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.